Mckesson (MCK) Non-Current Deferred Tax Liability (2010 - 2026)
Mckesson (MCK) reported Non-Current Deferred Tax Liability of $1.3 billion for Q1 2026, up 29.25% year-over-year from $1.0 billion in Q1 2025, and up 20.04% quarter-over-quarter from $1.1 billion in Q4 2025.
Mckesson (MCK) Non-Current Deferred Tax Liability (2010 - 2026) Analysis & Trends
Mckesson (MCK) has 17 years of Non-Current Deferred Tax Liability data on file, last reported at $1.3 billion in Q1 2026.
- Non-Current Deferred Tax Liability for Q1 2026 came in at $1.3 billion, up 29.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 29.25% YoY), and the FY2026 annual result was $1.3 billion, up 29.25% from the prior year.
- Non-Current Deferred Tax Liability climbed to $1.3 billion in Q1 2026 per MCK's latest filing, from $1.1 billion in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $2.8 billion in Q1 2022 and troughed at $928.0 million in Q2 2024.
- A 5-year average of $1.4 billion and a median of $1.1 billion in 2023 frame the typical range for Non-Current Deferred Tax Liability.
- The sharpest annual moves came in 2024 and 2025: Non-Current Deferred Tax Liability surged 83.78% in 2024, then plunged 59.63% in 2025.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at $1.5 billion in 2022, then slumped by 33.24% to $978.0 million in 2023, then grew by 11.66% to $1.1 billion in 2024, then gained by 1.47% to $1.1 billion in 2025, then grew by 20.04% to $1.3 billion in 2026.
- Business Quant data shows MCK's Non-Current Deferred Tax Liability at $1.3 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.33 Bn |
| Mar 31, 2026 | 1.33 Bn |
| Dec 31, 2025 | 1.11 Bn |
| Dec 31, 2025 | 1.11 Bn |
| Sep 30, 2025 | 1.09 Bn |
| Sep 30, 2025 | 1.09 Bn |
| Jun 30, 2025 | 987.00 Mn |
| Jun 30, 2025 | 987.00 Mn |
| Mar 31, 2025 | 1.03 Bn |
| Mar 31, 2025 | 1.03 Bn |
| Dec 31, 2024 | 1.09 Bn |
| Dec 31, 2024 | 1.09 Bn |
| Sep 30, 2024 | 1.05 Bn |
| Sep 30, 2024 | 1.05 Bn |
| Jun 30, 2024 | 928.00 Mn |
| Jun 30, 2024 | 928.00 Mn |
| Mar 31, 2024 | 2.55 Bn |
| Mar 31, 2024 | 2.55 Bn |
| Dec 31, 2023 | 978.00 Mn |
| Dec 31, 2023 | 978.00 Mn |